Biyun Wang

21PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPanel data analysisGlycoconjugatesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Mar 30, 2026
Effectiveness, safety, and biomarker analysis of sacituzumab govitecan in Chinese metastatic breast cancer: a multicenter real-world study.

Mu Li, Die Sang, Jin-Feng Zhang

|Nov 24, 2025
Development and validation of nomograms of outcomes for first-line platinum-based chemotherapy for metastatic triple-negative breast cancer: patient-level analysis of five prospective clinical trials in China.

Chengcheng Gong, Ting Li, Yifan Chen

|Nov 23, 2025
Real-world application of 18F-FES PET/CT on HR + breast cancer patients with brain metastases.

Shuting Li, Yizhao Xie, Cheng Liu

|Nov 03, 2025
Site-specific ligase-dependent conjugation with ring-opening linker improves safety and stability of HER2-targeting ADCs.

Lei Huang, Gang Qin, Chengcheng Gong

|Sep 03, 2025
Efficacy and safety of utidelone in pretreated patients with metastatic breast cancer in China: a multicenter, real-world study.

Shihui Hu, Tengfei Chao, Ning Xie

|Mar 04, 2025
Ferroptosis-related genes as prognostic markers for survival and immunotherapy in triple-negative breast cancer: analysis of public databases and a single institution.

Yizhao Xie, Zhonghua Tao, Biyun Wang

Pageof 4

Frequent Collaborators

4 joint publications

Xichun Hu

4 joint publications

Zhongyi Yang

3 joint publications

Zhonghua Tao

3 joint publications

Yifan Chen